FDA Will Revamp Advisory Panels

The FDA relies heavily upon advisory panels of scientists to make determinations concerning a drug’s safety, its potential side effects and make prescription recommendations. However, these advisory panels have come under scrutiny and at times, criticism, for financial ties some of the scientists have with the pharmaceutical companies. These conflict of interest issues are the main reason that the FDA is planning to revamp these advisory panels.